Clearmind Medicine (CMND) Cash & Equivalents Growth (1y) (2022 - 2026)
Clearmind Medicine (CMND) Cash & Equivalents Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 23.56% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.05% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 71.81% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 34.71% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 84.98% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.39% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -14.35% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -57.58% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 28.50% |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 155.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 155.24% |
| Jan 31, 2026 | 60.14% |
| Oct 31, 2025 | -40.32% |
| Jul 31, 2025 | -54.49% |
| Apr 30, 2025 | -46.15% |
| Jan 31, 2025 | -37.74% |
| Oct 31, 2024 | 21.12% |
| Jul 31, 2024 | 99.61% |
| Apr 30, 2024 | 58.34% |
| Jan 31, 2024 | 175.60% |
| Oct 31, 2023 | 4,001.52% |
| Jan 31, 2023 | 51.64% |
| Oct 31, 2022 | -96.38% |